High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients
✍ Scribed by Michael J Zelefsky; Zvi Fuks; Margie Hunt; Yoshiya Yamada; Christine Marion; C.Clifton Ling; Howard Amols; E.S Venkatraman; Steven A Leibel
- Book ID
- 108434786
- Publisher
- Elsevier Science
- Year
- 2002
- Tongue
- English
- Weight
- 72 KB
- Volume
- 53
- Category
- Article
- ISSN
- 0360-3016
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## Background Our aim was to review Memorial Sloan‐Kettering Cancer Center's experience with postoperative intensity‐modulated radiotherapy (IMRT) for paranasal sinus, nasal cavity, and lacrimal gland cancer and report dosimetric measures, toxicity, and outcomes. ## Methods Between S
## Abstract ## BACKGROUND Declines in serum hemoglobin (Hgb) levels occur from the use of androgen suppression therapy (AST) in the treatment of prostate cancer patients. We studied whether time to prostate specific antigen (PSA) failure following external beam radiation therapy (RT) and AST could